EPISODE · Sep 13, 2016 · 7 MIN
Dr. Scott Kutz Talks About Eric Claptons Condition
from Spine Talk · host Texas Back Institute
Eric Clapton, one of the world’s best-known blues and rock guitarists, has been playing his instrument professionally since 1962 and now, at age 71, he is being forced to seriously consider retirement. This has nothing to do with his popularity. In fact, he released a new album of songs entitled “I Still Do” in May 2016, to rave reviews. According to a recent article in the Washington Post, Clapton is experiencing nerve damage which is making it extremely painful to play guitar. He was quoted in the article. “I’ve had quite a lot of pain over the last year,” Clapton told “Classic Rock” Magazine. “It started with lower back pain and turned into what they call peripheral neuropathy, which is where you feel like you have electric shocks going down your leg. And I’ve had to figure out how to deal with some other things from getting old.” As the most recent addition to the Texas Back Institute team of spine experts, Dr. Scott Kutz, specializes in neurosurgery and, in addition to being an Eric Clapton fan, has several insights about this painful condition. “Peripheral neuropathy is a disorder affecting the peripheral nerves of the body, which is a part of the central nervous system,” he said. “This can affect one nerve, in which case it is known as a mono-neuropathy, or it can affect multiple nerves where it is known as a poly-neuropathy. “This condition is fairly common and there are several different types and multiple causes of neuropathy. In the case of a mono-neuropathy, the most common type is carpal tunnel syndrome , where the medial nerve is compressed in the area of the wrist and causes pain, tingling, numbness, swelling and it can affect one’s strength. For the Full story visit www.texasback.com/blog
NOW PLAYING
Dr. Scott Kutz Talks About Eric Claptons Condition
No transcript for this episode yet
Similar Episodes
Apr 22, 2026 ·65m
Apr 22, 2026 ·50m
Apr 15, 2026 ·61m
Apr 15, 2026 ·51m
Apr 9, 2026 ·59m
Apr 8, 2026 ·47m